Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

Dow Jones component Johnson & Johnson (JNJ) could buy out biotech stock MeiraGTx (MGTX) for its efforts in gene therapy, an analyst suggested Friday.